Serum Magnesium Levels and Hospitalization and Mortality in Incident Peritoneal Dialysis Patients: A Cohort Study

American Journal of Kidney Diseases

Volumn 68, Issue 4, 2016, Pages 619-627

  Yang, Xiao ^a   Soohoo, Melissa ^b   Streja, Elani ^b   Rivara, Matthew B ^c   Obi, Yoshitsugu ^b   Adams, Scott V ^c   Kalantar Zadeh, Kamyar ^b   Mehrotra, Rajnish ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

all cause mortality; end stage renal disease (ESRD); hospitalization; hypomagnesemia; incident PD patients; Magnesium; peritoneal dialysis (PD)

Indexed keywords

MAGNESIUM; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ALL CAUSE MORTALITY; ARTICLE; COHORT ANALYSIS; DEATH; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; UNITED STATES; AGED; BLOOD; KIDNEY FAILURE, CHRONIC;

AGED; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNESIUM; MALE; PERITONEAL DIALYSIS;

EID: 84973883720     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.03.428     Document Type: Article

References (26)

1. 1 Ayuk, J., Gittoes, N.J., Contemporary view of the clinical relevance of magnesium homeostasis. Ann Clin Biochem 51 (2014), 179–188.
2. 2 Lowenstein, F.W., Stanton, M.F., Serum magnesium levels in the United States, 1971-1974. J Am Coll Nutr 5 (1986), 399–414.
3. 3 Alhosaini, M., Leehey, D.J., Magnesium and dialysis: the neglected cation. Am J Kidney Dis 66 (2015), 523–531.
4. 4 Kanbay, M., Yilmaz, M.I., Apetrii, M., et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 36 (2012), 228–237.
5. 5 Van Laecke, S., Nagler, E.V., Verbeke, F., Van Biesen, W., Vanholder, R., Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med 126 (2013), 825–831.
6. 6 Li, L., Streja, E., Rhee, C.M., et al. Hypomagnesemia and mortality in incident hemodialysis patients. Am J Kidney Dis 66 (2015), 1047–1055.
7. 7 Lacson, E. Jr., Wang, W., Ma, L., Passlick-Deetjen, J., Serum magnesium and mortality in hemodialysis patients in the United States: a cohort study. Am J KIdney Dis 66 (2015), 1056–1066.
8. 8 Ejaz, A.A., McShane, A.P., Gandhi, V.C., Leehey, D.J., Ing, T.S., Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution. Perit Dial Int 15 (1995), 61–64.
9. 9 Rippe, B., Venturoli, D., Simonsen, O., de Arteaga, J., Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model. Perit Dial Int 24 (2004), 10–27.
10. 10 Ye, H., Zhang, X., Guo, Q., et al. Prevalence and factors associated with hypomagnesemia in Southern Chinese continuous ambulatory peritoneal dialysis patients. Perit Dial Int 33 (2013), 450–454.
11. 11 Fine, J.P., Grey, R.J., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.
12. 12 Saran, R., Li, Y., Robinson, B., et al. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 66:1 suppl 1 (2015), S1–S306.
13. 13 Wang, A.Y., Brimble, K.S., Brunier, G., et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part II - management of various cardiovascular complications. Perit Dial Int 35 (2015), 388–396.
14. 14 Wang, A.Y., Brimble, K.S., Brunier, G., et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I - assessment and management of various cardiovascular risk factors. Perit Dial Int 35 (2015), 379–387.
15. 15 Averbukh, Z., Rosenberg, R., Galperin, E., et al. Cell-associated magnesium and QT dispersion in hemodialysis patients. Am J Kidney Dis 41 (2003), 196–202.
16. 16 Maier, J.A., Malpuech-Brugere, C., Zimowska, W., Rayssiguier, Y., Mazur, A., Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 1689 (2004), 13–21.
17. 17 He, K., Liu, K., Daviglus, M.L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113 (2006), 1675–1682.
18. 18 Louvet, L., Buchel, J., Steppan, S., Passlick-Deetjen, J., Massy, Z.A., Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28 (2013), 869–878.
19. 19 Dey, R., Rajappa, M., Parameswaran, S., Revathy, G., Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk. Clin Exp Nephrol 19 (2015), 1054–1061.
20. 20 Fein, P., Suda, V., Borawsky, C., et al. Relationship of serum magnesium to body composition and inflammation in peritoneal dialysis patients. Adv Perit Dial 26 (2010), 112–115.
21. 21 Wang, Q., Bernardini, J., Piraino, B., Fried, L., Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 41 (2003), 664–669.
22. 22 Fan, X., Huang, R., Wang, J., et al. Risk factors for the first episode of peritonitis in Southern Chinese continuous ambulatory peritoneal dialysis patients. PloS One, 9, 2014, e107485.
23. 23 Sakaguchi, Y., Fujii, N., Shoji, T., Hayashi, T., Rakugi, H., Isaka, Y., Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 85 (2014), 174–181.
24. 24 de Roij van Zuijdewijn, C.L., Grooteman, M.P., Bots, M.L., et al. Serum magnesium and sudden death in European hemodialysis patients. PloS One, 10, 2015, e0143104.
25. 25 Fein, P., Weiss, S., Ramos, F., Singh, P., Chattopadhyay, J., Avram, M.M., Serum magnesium concentration is a significant predictor of mortality in peritoneal dialysis patients. Adv Perit Dial 30 (2014), 90–93.
26. 26 Doweiko, J.P., Nompleggi, D.J., The role of albumin in human physiology and pathophysiology, part III: albumin and disease states. JPEN J Parenter Enteral Nutr 15 (1991), 476–483.